Harvard Bioscience, Inc. (HBIO)
8.09
-0.22
(-2.65%)
USD |
NASDAQ |
Oct 16, 16:00
8.09
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience SG&A Expense (TTM) : 38.06M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 38.06M |
| March 31, 2026 | 36.84M |
| December 31, 2025 | 36.96M |
| September 30, 2025 | 37.94M |
| June 30, 2025 | 39.71M |
| March 31, 2025 | 41.99M |
| December 31, 2024 | 43.70M |
| September 30, 2024 | 45.01M |
| June 30, 2024 | 45.99M |
| March 31, 2024 | 46.44M |
| December 31, 2023 | 46.89M |
| September 30, 2023 | 47.19M |
| June 30, 2023 | 47.80M |
| March 31, 2023 | 48.83M |
| December 31, 2022 | 49.53M |
| September 30, 2022 | 51.18M |
| June 30, 2022 | 50.68M |
| March 31, 2022 | 50.24M |
| December 31, 2021 | 48.95M |
| September 30, 2021 | 46.64M |
| June 30, 2021 | 44.99M |
| March 31, 2021 | 42.81M |
| December 31, 2020 | 43.42M |
| September 30, 2020 | 43.71M |
| June 30, 2020 | 45.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 46.25M |
| December 31, 2019 | 45.87M |
| September 30, 2019 | 46.98M |
| June 30, 2019 | 45.76M |
| March 31, 2019 | 46.75M |
| December 31, 2018 | 45.82M |
| September 30, 2018 | 42.00M |
| June 30, 2018 | 39.27M |
| March 31, 2018 | 35.37M |
| December 31, 2017 | 32.61M |
| September 30, 2017 | 34.14M |
| June 30, 2017 | 35.99M |
| March 31, 2017 | 38.65M |
| December 31, 2016 | 41.44M |
| September 30, 2016 | 41.47M |
| June 30, 2016 | 41.70M |
| March 31, 2016 | 41.43M |
| December 31, 2015 | 40.41M |
| September 30, 2015 | 39.62M |
| June 30, 2015 | 37.83M |
| March 31, 2015 | 36.33M |
| December 31, 2014 | 34.98M |
| September 30, 2014 | 30.91M |
| June 30, 2014 | 32.40M |
| March 31, 2014 | 34.08M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Agilent Technologies, Inc. | 1.844B |
| Bio-Rad Laboratories, Inc. | 852.20M |
| Bruker Corp. | 970.70M |
| Danaher Corp. | 7.949B |
| Illumina, Inc. | 1.132B |